Consideration received

$

37,000

Carrying value of assets:

Assets

(33

)

Liabilities

333

Carrying value

300

Transaction costs

(3,160

)

Allocated license revenue for alpha-amylase and xylanase enzyme

(1,520

)

Deferred revenue associated with undelivered elements

(1,342

)

Gain on sale of oilseed processing business

$

31,278